tirzepatide update today Big in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Tirzepatide trial shows additional 21.1%

References Gadde K.M., et al., Obesity: Pathophysiology and Management

If you or a loved one developed sudden or permanent vision loss after taking Ozempic, Wegovy, Mounjaro, Zepbound, or Rybelsus, you may qualify to file a GLP-1 lawsuit and pursue financial compensation

Signs That Hair Regrowth Is Underway Decreased shedding of hair in the shower or on your brush New hairs, fine baby hairs, are appearing along the hairline and crown Increased thickness of hair strands, feeling stronger and fuller over time When to Consider Mental Health Support Hair thinning can affect confidence and mood

Newswise Since a study published last year found that patients taking GLP-1 drugs the active ingredient in Ozempic and Wegovy may be at higher risk of developing an eye condition that can cause blindness, researchers have been working to learn more about a possible connection to vision loss

Chlorin-based nanoscale metal-organic framework systemically rejects colorectal cancers via synergistic photodynamic therapy and checkpoint blockade immunotherapy

"GLP-1 medications have made weight management more attainable, which means patients can now turn their attention to other aspects of their health and confidence." The journey beyond the scale Whitney Quartey can relate